Stay updated with breaking news from Yuning Hong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On Monday (30 October 2023), the Australian Research Council (ARC) announced funding as part of the ARC Discovery Projects scheme.Professor Susan Dodds, Senior Deputy Vice-Chancellor (Research and Industry Engagement) said the announcement is testame
Credit: ©Science China Press Immunotherapy is a type of anti-tumor treatment and has shown great clinical success against a wide variety of malignancies in recent years. Poly(I : C), a TLR3 agonist, is the most potent type I interferon (IFN) inducer. Poly(I : C) not only directly induces tumorous apoptosis, but also stimulates tumor cells to secrete immune factors. However, the immune response rate induced by Poly(I : C) remains low in several types of malignancies and higher doses are often required to achieve the desired effect. However, poly(I : C) is highly toxic and thus only a very nar...